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Abstract
We investigated the multivariate dimensionality and strength of the relationship between metabolic syndrome (MetS) and
inflammation in children. Caucasian school children (N = 229; 12–14 years) fromWales were tested on several health indicators
including measures of body composition, inflammation, fasting glucose regulation, blood pressure, and lipids. The multivariate
association between MetS and inflammation was investigated via canonical correlation analysis. Data were corrected for non-
normality by log transformation, and sex-specific z-scores computed for variables where there was a significant sex difference.
Structure r’s were interpreted to determine the dimensions of MetS and inflammation responsible for significant canonical
variates. The overall multivariate association between MetS and inflammation was significant (Wilks’ Lambda = 0.54,
p < 0.001). The relationship was explained primarily by the waist circumference dimension of MetS (CC = 0.87) and inflamma-
tory markers of fibrinogen (CC = 0.52) and C-reactive protein (CC = 0.50). The pattern of results was similar regardless of
whether variables were adjusted for sex differences.
Conclusion: Central adiposity is the strongest predictor of the inflammatory aspect of cardiovascular disease risk in Caucasian
adolescents. Future research into MetS and cardiometabolic risk should consider multivariate statistical approaches, in order to
identify the separate contributions of each dimension in interrelationships and to identify which dimensions are influenced by
preventive interventions.
What is Known:
•Metabolic syndrome (MetS) is associated with increased risk of cardiovascular disease (CVD) and type 2 diabetes. Markers of inflammation are also
potential predictors of later development of CVD and type 2 diabetes.
• The contribution of individual markers in interrelationships between MetS and inflammation is unknown.
What is New:
• We uniquely demonstrate that within a multivariate model, waist circumference is the primary link between MetS variables and markers of
inflammation in children.
• Waist circumference may therefore be a useful population-level screening tool to identify future risk of CVD.
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Abbreviations
CC Canonical coefficient
CRP C-reactive protein
CVD Cardiovascular disease
Fg Fibrinogen
HDL-C High-density lipoprotein cholesterol
HMW High molecular weight
IL-6 Interleukin-6
LDL-C Low-density lipoprotein cholesterol
MetS Metabolic syndrome
T2DM Type 2 diabetes mellitus
TC Total cholesterol
TG Triglycerides
Introduction
Cardiovascular disease (CVD) continues to be a major cause
of morbidity and premature mortality in developed countries
and, to an increasing degree, in low- andmiddle-income coun-
tries as well. It has long been thought that CVD has its origins
in childhood [21] and epidemiological evidence has revealed
that many children exhibit at least one CVD risk factor [2, 30].
Type 2 diabetes mellitus (T2DM), which shares several risk
factors with CVD, is now established as a condition not only
affecting adults but also adolescents and children with
resulting mortality and morbidity in early adult life [25]. The
early identification in childhood or adolescence of those at risk
of later CVD and T2DM may allow a targeted approach by
lifestyle measures to prevent or delay the onset of these con-
ditions in later life. Several of the risk factors for CVD and
T2DM are related to obesity. Despite early indications that the
prevalence of obesity in children has plateaued in several
countries [22], childhood and adolescent obesity and their
consequences are still major public health problems.
The prevalence of the metabolic syndrome (MetS), a clus-
ter of cardiometabolic risk factors associatedwith an increased
risk for the development of cardiovascular diseases and
T2DM, is as high as 30–50% among overweight youth [17].
Traditional risk factors such as abdominal obesity, hyperten-
sion, elevated fasting blood glucose and triglycerides (TG),
and reduced high-density lipoprotein cholesterol (HDL-C)
are encompassed in the many definitions of the MetS. A joint
scientific statement, led by the International Diabetes
Federation and the American Heart Association along with
four other bodies, defined MetS in adults as three abnormal
findings out of the above five variables, with abdominal obe-
sity indicated by waist circumference [1]. A consensus defini-
tion for MetS in children and adolescents has not yet been
developed. There are currently at least 40 unique definitions
of MetS for this age group [9], and the prevalence of MetS
varies depending on the definition used [32]. Weiss and col-
leagues [33] argued that the environment plays a major role in
the development of MetS, in particular the typical Western
diet, which has now been adopted globally due to palatability
and price. They suggest thatMetS is instigated withmitochon-
drial overload and results in de novo lipogenesis, insulin re-
sistance, and dysfunctional subcellular energy use.
Markers of systemic inflammation such as fibrinogen, C-
reactive protein (CRP), interleukin-6 (lL-6), and adiponectin
are also of considerable interest as potential predictors of the
later development of CVD [6] and T2DM [34]. The evidence
relating to CVD and T2DM risks, markers of inflammation
and obesity in adolescents, has recently been reviewed [4, 13].
The adipocytes of visceral adipose tissue secrete a variety of
cytokines and adipokines including interleukin-6 (IL-6) and,
when hypertrophied, low levels of adiponectin. High concen-
trations of IL-6 and low concentrations of adiponectin are
associated with systemic inflammation and insulin resistance,
respectively. Systemic inflammation, which increases levels
of CRP [7], stimulates pathological arterial intimal changes
which are part of the basis for later CVD, while insulin resis-
tance forms the key pathological change leading to T2DM.
Even low levels of circulating CRP (2–6 mg/L), so called
Bhigh-sensitivity CRP^ (hs-CRP), are indicative of an active
inflammatory response to abdominal obesity in adults [26].
DeBoer [4] considered the evidence linking systemic inflam-
mation to CVD risk in adults to be stronger than that relating
to insulin resistance and T2DM but commented that long-term
data linking increased hs-CRP levels—and increased insulin
or decreased adiponectin—in childhood to adult disease out-
comes are currently lacking. Nevertheless, he postulated that
clinical and laboratory tests (among them, by implication,
those relating to the MetS and inflammation as potential can-
didates) might be used as Bscreening tests^ to facilitate the
identification of adolescents at risk of CVD and T2DM with
a view to ultimately improving prevention efforts.
Consensus is lacking regarding appropriate screening to
identify the interrelated conditions of MetS and systemic in-
flammation in children which lead to the development of
CVD in later life. Such advances require greater understand-
ing of the separate contributions of each of the multiple com-
ponents of MetS in the relationship between MetS and health
outcomes, many of which are themselves multidimensional.
In the previous studies of MetS, or cardiometabolic health, a
univariate statistical approach is often used, which can mask
the separate contributions of the MetS components. For ex-
ample, it is common to classify MetS as a single condition
(i.e., by classifying MetS as Bpresent^ or Babsent^) [11] or by
combining the components into a composite z-score [5]. Other
studies that include the components of MetS conduct separate
analyses for each of the components [15]. Multivariate statis-
tical techniques have been used in the social sciences for many
years, to investigate relationships between determinants (in-
dependent variables) and outcome variables (dependent vari-
ables) that are multidimensional in nature. These techniques
are used less in the biological sciences, but are nevertheless
valuable where the variables under investigation are
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multivariate in nature (i.e., they consist of several related di-
mension, as is the case with MetS). The purpose of this study
was therefore to investigate the multivariate dimensionality
and strength of the relationship between MetS components
and inflammatory markers in adolescent children.
Methods
The study is part of Prosiect Sir Gâr (The Carmarthenshire
Project). Early results focusing on secular trends in CVD risk
among 11–12 year olds have already been published [31]. The
study was approved by the Dyfed-Powys NHS Research
Ethics Committee.
Participants
Pupils from three secondary schools in Carmarthenshire were
asked to participate in the study which was integrated into the
schools’ physical education program. Participant and parent/
guardian information sheets and consent and assent forms
were distributed to all year eight school children (age 12–
14 years). Informed consent was obtained from all individual
participants included in the study.
Measures
All physical and physiological measurements were performed
by the principal investigator and a trained research assistant.
Protocols followed the Anthropometric Standardization
Reference Manual [16]. Participants were dressed in shorts
and t-shirt, and without footwear. Standing height was mea-
sured to the nearest millimeter using a portable stadiometer.
Body mass was measured to the nearest tenth of a kilogram
(kg) using a Phillips HP 5320 electronic scale (Philips UK,
Ltd., Guilford, Surrey) calibrated against a balanced beam
scale. Body mass index (BMI) was derived as the mass divid-
ed by stature squared (kg/m2) for each participant. Waist cir-
cumference was measured at the narrowest point between the
lower rib border and the iliac crest using an anthropometric
tape (Holtain Ltd., Crymych, Pembrokeshire, UK). Tanner
stage maturational status was determined using a self-
administered assessment form of secondary sexual character-
istics that was previously validated against physical examina-
tion by a physician in 12–16-year-old children [29].
Blood pressure readings were taken using a Dinamap au-
tomatic BP monitor. Participants were seated, and blood pres-
sure was taken in the morning with the participant fasted and
not having undertaken vigorous exercise during the 30 min
preceding the measurement. Blood pressure was recorded
three times, and the average of the second and third reading
was recorded.
Blood samples were collected between 9.00 am and
11.00 am, following an overnight fast. To control for plasma
volume shifts, venous blood was sampled after the participant
had assumed a seated position for at least 30 min [24].
Samples were analyzed for total cholesterol (TC), HDL-C,
low-density lipoprotein cholesterol (LDL-C), TG, glucose,
fibrinogen (Fg), high molecular weight (HMW) adiponectin,
CRP, and IL-6. TC and TG concentrations were estimated by
routine enzymatic techniques using the Vitros 950 System
(Ortho-Clinical Diagnostics, Amersham, Bucks, UK). The
concentration of HDL-C was determined after precipitation
of very low-density and LDL-C with dextran sulfate and mag-
nesium chloride. LDL-C concentration was calculated by the
Friedewald formula [10]. Fibrinogen concentration was deter-
mined according to the method of Clauss [3] and using the
ACL Futura analyzer (Instrumentation Laboratory Company,
Lexington, MA). CRP concentration was measured by an
immunoturbidimetric method using the Cobas Fara (Roche,
Welwyn Garden, UK).
Statistical analysis
All primary outcome variables were initially screened for out-
liers, data errors, and normality by running frequencies, cal-
culating distribution statistics, and inspecting histograms.
Three CRP scores reported as < 0.1 in the blood assay report
were changed to 0.09, to facilitate statistical analysis. This
pragmatic decision was taken on the basis that it would not
meaningfully alter the distribution of the data and to exclude
all data from participants who had contributed fully to the
study would be otherwise unethical. Two high hs-CRP values
were indicative of acute infection and were replaced using
simple regression on IL-6, with which it had the highest bi-
variate correlation. Two variables (hs-CRP and IL-6) did not
have a normal distribution, defined as having skewness and
kurtosis values > |2.0|, and these were transformed using the
natural log (Ln). This reduced skewness and kurtosis values
below |2.0|, enabling their subsequent analysis using paramet-
ric statistics. Boys and girls were compared using independent
t tests to determine any sex differences. Following significant
differences for TG, glucose, waist circumference, adiponectin,
LnCRP, and LnIL-6, sex-specific z-scores were calculated for
these variables.
The primary research question was investigated using ca-
nonical correlation analysis. Canonical correlation analysis
determines the multivariate association between two sets of
variables, where each set consists of multiple related out-
comes. In the current study, MetS comprises a set of related
components, and inflammation was represented by a set of
related inflammatory markers. Two canonical variates are cal-
culated to obtain the maximal observed correlation between
the two sets of variables (characterized here as the indepen-
dent variables—diastolic blood pressure, systolic blood
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pressure, HDL-cholesterol, TG, glucose, and waist circumfer-
ence, and the dependent variables—Fg, adiponectin, hs-CRP,
and IL-6). Additional canonical variates are calculated to de-
termine whether additional common variance can be ex-
plained. If significant canonical variates are found, canonical
coefficients and correlations between the variables and their
respective canonical variate help to explain the dimensionality
of the relationship—specifically, which of the multiple vari-
ables on each side of the relationship is responsible for
explaining the multivariate association. All statistical tests of
significance were conducted at a nominal alpha level of p =
0.05.
There are no software packages nor reference tables
for power associated with a canonical correlation analy-
sis. However, the significance test for a canonical func-
tion is equivalent to a Pearson correlation coefficient (as
it is the bivariate correlation between the two canonical
variates representing the two sets of underlying vari-
ables, and each canonical variate is a single, composite
value). Power analysis (G*Power version 3.1, Heinrich
Heine Universität Düsseldorf) indicated that, in order to
detect the frequently used ready-reference value of r =
0.30 (which equates approximately to 10% shared vari-
ance between the two sets of variables) at a power of
1-β = 0.80, a sample of n = 84 is required. A power of
1-β = 0.95 would be achieved with a sample of n = 138.
Our sample therefore provided a high level of statistical
power to detect any underlying correlations in the
population.
Results
Two hundred and sixty-eight participants took part in the
study. All were of Caucasian origin. Table 1 shows the basic
physical characteristics and biochemical measures of 229 par-
ticipants for whom complete data for the canonical correlation
analysis were available. Missing data were primarily for the
blood-based variables and were due to either inability to col-
lect blood, participant refusal, absence on the day of blood
testing, or insufficient blood collected to conduct the full set
of assays. Participants with missing blood data (n = 39) were
compared to participants with complete blood data on age,
BMI, sum of skinfolds, waist circumference, and both systolic
and diastolic blood pressure. Generally, there were no signif-
icant differences between groups, except for age (mean differ-
ence = 0.1 year, p = 0.044) and systolic blood pressure (mean
difference = 4 mmHg; p = 0.049). Maturational stage varied
within the sample, although the majority were at Tanner stage
3 (39 and 35% based on breast/penis development and pubic
hair distribution, respectively) or stage 4 (34%/41%).
Pearson zero-order correlations within and between the two
sets of variables are presented in Table 2.Within the set of four
dependent variables, three of six correlations were significant
at the p < 0.01 level, and within the set of six independent
variables, 10 of 15 variables were significant, with three being
significant at p < 0.05 and seven at the p < 0.01 level. The
highest within-set correlations were between CRP and Fg
(r = 0.58) and between diastolic and systolic blood pressure
(r = 0.51). Of the 24 correlations between the independent and
Table 1 Physical characteristics
and biochemical measures (mean
± SD) of participants
Boys (n = 95) Girls (n = 134) All (n = 229)
Demographic variables
Age (years) 13.54 (0.33) 13.49 (0.30) 13.51 (0.31)
Body mass (kg) 53.30 (13.23) 53.40 (11.44) 53.36 (12.18)
Height (m) 1.60 (0.90) 1.58 (0.66) 1.59 (0.77)
BMI (kg/m2) 20.60 (3.74) 21.31 (3.68) 21.02 (3.71)
Variables used in the multivariate analysis
Fg (g/L) 2.69 (0.44) 2.65 (0.46) 2.66 (0.45)
HMW-Ad (ng/mL) 2484.20 (1605.01) 3381.78 (1798.25) 3009.42 (1773.36)
hs-CRP (mg/L) 0.67 (0.72) 0.44 (0.59) 0.54 (0.66)
IL-6 (ng/ml) 0.97 (1.09) 0.73 (0.56) 0.83 (0.83)
Diastolic BP 64.73 (11.10) 65.62 (10.19) 65.25 (10.56)
Systolic BP 116.59 (12.55) 115.78 (10.57) 116.11 (11.41)
HDL-C (mmol/L) 1.63 (0.33) 1.71 (0.32) 1.68 (0.33)
TG (mmol/L) 0.63 (0.29) 0.75 (0.30) 0.70 (0.30)
Glucose (mmol/L) 4.92 (0.35) 4.81 (0.27) 4.86 (0.31)
Waist circumference (cm) 68.41 (9.29) 65.79 (8.33) 66.88 (8.82)
BMI body mass index,WCwaist circumference, BP blood pressure,HDL-C high-density lipoprotein cholesterol,
TG triglyceride, Fg fibrinogen,HMW-Ad high molecular weight adiponectin, hs-CRP high-sensitivity C-reactive
protein, IL-6 interleukin-6
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dependent variables, five were significant at the p < 0.05 level
and nine were significant at the p < 0.01 level. The highest
between-set correlations were between waist circumference
and Fg (r = 0.51) and between waist circumference and CRP
(r = 0.48).
The results of the canonical correlation analysis are shown
in Tables 3 and 4. As shown in these tables, the pattern of
results was similar regardless of whether the variables were
adjusted for sex differences. We have focused on the sex-
specific results, presented in Table 3, although the results were
ostensibly the same. The pattern of coefficients is also illus-
trated in Fig. 1. The overall multivariate association between
MetS and inflammation was significant (Wilks’ Lambda =
0.56, p < 0.001), indicating a significant association between
the two sets of variables. There was 36% shared variance
between the two sets of variables. Only the first canonical
functionwas significant (p < 0.05). Inspection of the canonical
coefficients (CC) in Table 3 helps to explain which of the
underlying components of MetS and markers of inflammation
are primarily responsible for the multivariate association.
Similar to techniques such as factor analysis, the CCs can be
viewed as loadings of each variable, or components, on the
canonical variate. Higher CCs indicate a more statistically
Table 2 Zero-order correlations between and within dependent and independent variables
Dependent variables Independent variables
Fg HMW-Ad (z) LnCRP (z) LnIL-6 (z) DBP SBP HDL-C TG (z) Glucose (z) WC (z)
Fg 1.0
HMW-Ad (z) − 0.10 1.0
LnCRP (z) 0.58** 0.01 1.0
LnIL-6 (z) 0.42** 0.02 0.41** 1.0
DBP 0.28** 0.05 0.30** 0.24** 1.0
SBP 0.12 − 0.03 0.14* 0.25** 0.51** 1.0
HDL-C − 0.21** 0.12 − 0.16* − 0.17* − 0.03 − 0.01 1.0
TG (z) 0.28** − 0.10 0.13* 0.09 0.20** 0.03 − 0.42** 1.0
Glucose (z) 0.05 − 0.09 0.08 0.06 0.08 0.16* − 0.07 0.16* 1.0
WC (z) 0.51** − 0.16* 0.48** 0.30** 0.33** 0.23** − 0.33** 0.33** 0.13* 1.0
Fg fibrinogen, CRP C-reactive protein, IL-6 interleukin-6, BP blood pressure, HDL-C high-density lipoprotein cholesterol, TG triglyceride, (z) sex-
specific z-score
*p < 0.05; **p < 0.01
Table 3 Canonical correlation analysis results for sex-specific z-scores
Standardized
canonical
coefficient
Correlation between
variable and canonical
variate
Dependent variables
Fg − 0.58 − 0.90
HMW-adiponectin (z) 0.20 0.25
LnCRP (z) − 0.44 − 0.82
LnIL-6 (z) − 0.11 − 0.54
Independent variables
Diastolic BP − 0.25 − 0.52
Systolic BP 0.03 − 0.28
HDL-C 0.06 0.38
TG (z) − 0.04 − 0.39
Glucose (z) − 0.02 − 0.14
Waist circumference (z) − 0.86 − 0.97
Fg fibrinogen,CRPC-reactive protein, IL-6 interleukin-6,BP blood pres-
sure, HDL-C high-density lipoprotein cholesterol, TG triglyceride, (z)
sex-specific z-score
Table 4 Canonical correlation analysis results for non sex-specific z-
scores
Standardized
canonical
coefficient
Correlation between
variable and canonical
variate
Dependent variables
Fg − 0.52 − 0.87
HMW-adiponectin (z) 0.21 0.29
LnCRP (z) − 0.50 − 0.85
LnIL-6 (z) − 0.12 − 0.55
Independent variables
Diastolic BP − 0.25 − 0.50
Systolic BP 0.04 − 0.28
HDL-C 0.10 0.41
TG (z) − 0.04 − 0.30
Glucose (z) − 0.06 − 0.20
Waist circumference (z) − 0.87 − 0.97
Fg fibrinogen,CRPC-reactive protein, IL-6 interleukin-6,BP blood pres-
sure, HDL-C high-density lipoprotein cholesterol, TG triglyceride, (z)
sex-specific z-score
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meaningful role played by the variable or components on the
underlying canonical variate. Thus, Table 3 indicates that the
multivariate relationship was explained primarily by the waist
circumference component of MetS (CC = − 0.86) and inflam-
matory markers of fibrinogen (CC = − 0.58) and CRP (CC =
− 0.44). CCs between HMW-adiponectin (CC = 0.20) and IL-
6 (CC = − 0.11) and the inflammation canonical variate were
much lower.
Discussion
This study presents a novel approach to understanding the link
between MetS and inflammatory markers in a large sample of
apparently healthy school children. Rather than the traditional
method of using MetS variables to classify children’s meta-
bolic status asMetS present/absent, we instead investigated all
MetS variables as separate, but interrelated, continuously dis-
tributed components. Metabolic status is a multiple variable or
multidimensional construct. Although evidence-based criteria
have been developed to classifyMetS status as present/absent,
there has been inconsistency in the literature regarding what
definitions should be used [14]. A review of the topic identi-
fied 40 unique definitions of MetS in children and adolescents
[9]. While an attempt at harmonizing the definition for adults
has been made jointly by several bodies [1], a consensus def-
inition for children and adolescents is lacking. Dichotomous
variable categorizations are difficult to define in a clear and
unbiased way due to lack of specific normative values for all
criteria included in the syndrome and for all populations [17].
Further, use of the MetS concept with children remains con-
troversial [23]. Indeed, it has been suggested that as the appli-
cation of the MetS model has not been fully validated in chil-
dren and adolescents as yet, diagnosis, prevention, and treat-
ment should better focus on established risk factors rather than
the diagnosis of MetS [14]. Finally, classification of MetS as a
univariate, dichotomous construct does not enable
investigation of the contribution of individual components to
important physiological mechanistic variables such as inflam-
matory markers. The same is true of expressing metabolic
status as a composite score (by combining the z-scores for
separate components), which (a) results in a single score and
(b) weights every component equally, potentially masking a
differential contribution to health risk of each of the compo-
nents. The multivariate analysis used in this study demon-
strates the importance of allowing the MetS components to
be investigated simultaneously within a single analysis, while
also enabling the teasing out of separate contributions of each
of the underlying components.
Results of the canonical correlation analysis point clearly to
waist circumference being the component of the MetS most
strongly associated with markers of systemic inflammation.
Of the plasma markers of inflammation, fibrinogen and CRP
primarily explain this association. Thus, waist circumference,
as a surrogate for central adiposity, was the strongest predictor
of the inflammatory aspect of CVD risk in these Caucasian
adolescents. While a relationship between waist circumfer-
ence and inflammation has previously been demonstrated in
cross-sectional studies [28], we establish for the first time the
multivariate dimensionality and strength of this relationship
considering other components of the MetS. This finding lends
support for the inclusion of abdominal obesity, indicated by a
waist circumference greater than the relevant age-specific cut-
off point, as an obligatory component in the definition of
metabolic syndrome in children and adolescents by the
International Diabetes Federation [35]. The mandatory use
of adiposity to define MetS has been subject to much debate
(for example see Zivkovic and German (2007) [36]). This
paper, therefore, will add to the evidence base should attempts
be made to reach a consensus definition, as has already been
achieved for adults [1].
While, to our knowledge, this is the first study that has
investigated associations between MetS and inflammation in
this age group, using a multivariate approach, some
Fig. 1 Canonical coefficients
between MetS components and
inflammation markers
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similarities existed within our univariate analyses with other
large-scale studies of MetS in children and youths. In a study of
girls and boys aged 6–14 years [18], a matrix of 153 zero-order
correlations was reported between a set of cardiometabolic risk
variables and anthropometric variables. The ratio of waist/height
correlated with a set of eight lipid markers, fasting glucose, and
resting blood pressure, with an average correlation of r= 0.14
across the eight variables. In our study, waist circumference cor-
related with the set of five lipid markers, fasting glucose, and
resting blood pressure variables with an average Pearson correla-
tion of r= 0.27.Waist/height ratio has also been reported as being
correlated with systolic blood pressure (r = 0.25) [19] and
triglyceride/HDL-C ratio (r= 0.25) [20] in two other studies of
children and adolescents between 6 and 14 years of age. Waist
circumference variables have therefore been shown to correlate
with other MetS variables in samples of children and youths
previously, albeit these studies did not report any markers of
inflammation. Interestingly, in our study, waist circumference
correlated highly and significantly with three of the four inflam-
matory markers, and generally correlated more highly with the
inflammatory markers than with the other MetS components.
These findings regarding waist circumference may also have
practical implications for possible steps in diagnosis of and
screening for metabolic syndrome at individual and population
level. Any consideration of clinical and biochemical parameters
for the early identification of CVD and T2DM risk in children
and adolescents must consider not only what parameters would
be most useful and feasible to measure, but also what is meant
by Bscreening^ as a means of early detection. Sackett and
Holland (1975) drew important distinctions between the detec-
tion of disease in the context of diagnosis (in which individual
patients relate to individual clinicians) and Bcase-finding^
(screening as a population-based procedure) [27]. Population-
based screening, in which apparently healthy individuals are
invited to participate, has the implicit promise of benefits over
and above those which would accrue if individuals had waited
until they sought medical advice as individuals. For early de-
tection of risk of CVD and T2DM, any advocate of population-
based screening must be assured that there is adequate evidence
of the benefits and accuracy of early detection by screening.
While acknowledging that the cross-sectional nature of our
findings limits the ability to infer that current associations
would be effective in predicting long-term risk, and noting the
moderately sized, homogenous sample recruited, the data pre-
sented here suggest an approach for screening. Measurement of
waist circumference together with the laboratory measurement
of fibrinogen and CRP could be considered as possible candi-
dates for a screening program. Waist circumference is non-
invasive and low-tech and can be carried out by a profession-
al—easily trained in the correct technique—as part of the clin-
ical consultation with an individual patient or as part of
population-based activities such as school-based health pro-
grams. Venous blood sampling for fibrinogen and CRP
measurement is somewhat more invasive and requires labora-
tory facilities. In a population-based program, a two-stage pro-
cess might be envisaged—first waist circumference and then,
on a high-risk sub-set, fibrinogen and CRP measurement.
Preference for selective screening of high-risk subgroups of
the population has long been advocated [8].
Limitations and strengths
Generalization of these results to other populations is limited
by the sample. Based on our sample, generalization should
therefore be restricted to Caucasian youths between the ages
of 12 and 14 years. Additionally, although maturational status
was related to MetS in previous studies [32], we were unable
to investigate this in our study due to the relative homogeneity
of maturational status in our sample (approximately 75% of
the sample were at Tanner stages 3 and 4). Strengths of the
study include use of a novel and appropriate analysis tech-
nique, canonical correlation analysis that allowed the MetS
components to be investigated simultaneously within a single
analysis. This method was previously used to examine the
relationships between components of physical activity and
cardiorespiratory fitness versus CVD risk factors in children
and adolescents [12].
Conclusions
We demonstrate for the first time that within a multivariate
model, waist circumference is the primary link between
MetS variables and markers of inflammation in Caucasian
school children. We suggest that this measure of central adi-
posity may be a useful population-level screening tool to iden-
tify future risk of CVD. Future research into MetS and CVD
risk factors should consider multivariate statistical ap-
proaches, in order to identify the separate contributions of
each dimension in interrelationships and to identify which
dimensions are most influenced by preventive interventions.
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